European Medical Solutions
XBRU:ALEMS
European Medical Solutions
XBRU:ALEMS
Price:
5.36
EUR
Market Closed
Market Cap:
€22.7m
Relative Value
The Relative Value of one
ALEMS
stock under the Base Case scenario is
18.67
EUR.
Compared to the current market price of 5.36 EUR,
European Medical Solutions
is
Undervalued by 71%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALEMS
Relative Value
Base Case
18.67
EUR
Undervaluation 71%
Multiples Across Competitors
ALEMS Competitors Multiples
European Medical Solutions Competitors
European Medical Solutions Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| BE |
|
European Medical Solutions
XBRU:ALEMS
|
22.7m EUR | 0.5 | 19.4 | 7.8 | 16.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
409.8B USD | 6.9 | 174.4 | 16.8 | 23.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
198.7B USD | 5.4 | 25.8 | 14.8 | 14.8 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
193.1B USD | 6.6 | 23.8 | 16.2 | 16.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.5B USD | 10.6 | 33.9 | 25 | 26.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
84.3B USD | 5.9 | 18.7 | 14.2 | 16.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
72.6B AUD | 3.2 | 16.8 | 11.5 | 14.4 | |
| NL |
|
argenx SE
XBRU:ARGX
|
43.1B EUR | 14.4 | 33.9 | 57.9 | 59.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
